Arthritis Therapeutics Market
Arthritis Therapeutics Market Analysis by Type (Rheumatoid Arthritis, Osteoarthritis, Arthritis, Gout), By Drug Class, By Route of Administration, By Distribution Channel, By Region - Global Market Insights 2019 to 2027
Analysis of Arthritis Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT4355MR
- 10 Mar 2022
- Healthcare
- 170 Pages
- 30 Tables
- 89 Figures
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Key Insights
- 6. Global Market Analysis and Forecast, By Type
- 6.1. Rheumatoid Arthritis
- 6.2. Osteoarthritis
- 6.3. Psoriatic Arthritis
- 6.4. Gout
- 6.5. Others
- 7. Global Market Analysis and Forecast, By Drug Class
- 7.1. TNF Inhibitors
- 7.2. Interleukin Inhibitors
- 7.3. NSAIDs
- 7.4. Corticosteroids
- 7.5. Xanthine Oxidase Inhibitors
- 7.6. Others
- 8. Global Market Analysis and Forecast, By Route of Administration
- 8.1. Oral
- 8.2. Parenteral
- 8.3. Topical
- 9. Global Market Analysis and Forecast, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Online Pharmacies
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Europe
- 10.3. Asia Pacific
- 10.4. Latin America
- 10.5. Middle East & Africa
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. Asia Pacific Market Analysis and Forecast
- 14. Latin America Market Analysis and Forecast
- 15. Middle East & Africa Market Analysis and Forecast
- 16. Competition Landscape
- 16.1. Novartis AG
- 16.2. Eli Lilly and Company
- 16.3. Amgen, Inc.
- 16.4. Merck & Co., Inc.
- 16.5. Bristol-Myers Squibb Company
- 16.6. Pfizer, Inc.
- 16.7. AbbVie, Inc.
- 16.8. Janssen Global Services, LLC (Johnson & Johnson)
- 16.9. F. Hoffmann-La Roche Ltd
- 16.10. Sanofi
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 02: Global Market Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 03: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027
Table 04: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 05: Global Market Value (US$ Mn) Forecast, by Region, 2017 to 2027
Table 06: North America Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 07: North America Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 08: North America Value (US$ Mn) Forecast, by Route of Administration,
Table 09: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 10: North America Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017 to 2027
Table 11: Europe Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 12: Europe Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 13: Europe Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027
Table 14: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 15: Europe Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 17: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 18: Asia Pacific Market Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027
Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 20: Asia Pacific Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027
Table 21: Latin America Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 22: Latin America Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 23: Latin America Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027
Table 24: Latin America Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 25: Latin America Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027
Table 26: Middle East & Africa Value (US$ Mn) Forecast, by Type, 2017 to 2027
Table 27: Middle East & Africa Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027
Table 28: Middle East & Africa Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027
Table 29: Middle East & Africa Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027
Table 30: Middle East & Africa Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027
List Of Figures
Figure 01: Global Market Snapshot
Figure 02: Global Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 03: Global Market Value (US$ Mn) Forecast, 2017 to 2027
Figure 04: Global Market Value Share (%), by Type (2018)
Figure 05: Global Market Value Share (%), by Route of Administration (2018)
Figure 06: Global Market Value Share (%), by Drug Class (2018)
Figure 07: Global Market Value Share (%), by Distribution Channel (2018)
Figure 08: Global Market Value Share (%), by Region (2018)
Figure 09: Global Market Value Share Analysis, by Type, 2018 and 2027
Figure 10: Global Market Attractiveness, by Type, 2019 to 2027
Figure 11: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017 to 2027
Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017 to 2027
Figure 13: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017 to 2027
Figure 14: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017 to 2027
Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017 to 2027
Figure 16: Global Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 17: Global Market Attractiveness, by Drug Class, 2019 to 2027
Figure 18: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017 to 2027
Figure 19: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017 to 2027
Figure 20: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017 to 2027
Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017 to 2027
Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017 to 2027
Figure 23: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017 to 2027
Figure 24: Global Market Value Share(%), by Route of Administration, 2018 and 2027
Figure 25: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017 to 2027
Figure 26: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017 to 2027
Figure 27: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017 to 2027
Figure 28: Global Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 29: Global Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 30: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017 to 2027
Figure 31: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017 to 2027
Figure 32: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017 to 2027
Figure 33: Global Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 34: Global Market Value Share Analysis, by Region 2018 and 2027
Figure 35: Global Market Attractiveness, by Region, 2019 to 2027
Figure 36: North America Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027
Figure 37: North America Market Value Share (%), by Type, 2018 and 2027
Figure 38: North America Market Attractiveness, by Type, 2019 to 2027
Figure 39: North America Market Value Share (%), by Drug Class, 2018 and 2027
Figure 40: North America Market Attractiveness, by Drug Class, 2019 to 2027
Figure 41: North America Market Value Share (%), by Route of Administration, 2018 and 2027
Figure 42: North America Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 43: North America Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 44: North America Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 45 : North America Market Value Share (%), By Country/Sub-region , 2018 and 2027
Figure 46: North America Market Attractiveness, By Country/Sub-region , 2019 to 2027
Figure 47: Europe Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027
Figure 48: Europe Market Value Share (%), by Type, 2018 and 2027
Figure 49: Europe Market Attractiveness, by Type, 2019 to 2027
Figure 50: Europe Market Value Share (%), by Drug Class, 2018 and 2027
Figure 51: Europe Market Attractiveness, by Drug Class, 2019 to 2027
Figure 52: Europe Market Value Share (%), by Route of Administration, 2018 and 2027
Figure 53: Europe Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 54: Europe Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 55: Europe Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 56: Europe Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
Figure 57: Europe Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027
Figure 58: Asia Pacific Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027
Figure 59: Asia Pacific Market Value Share (%), by Type, 2018 and 2027
Figure 60: Asia Pacific Market Attractiveness, by Type, 2019 to 2027
Figure 61: Asia Pacific Market Value Share (%), by Drug Class, 2018 and 2027
Figure 62: Asia Pacific Market Attractiveness, by Drug Class, 2019 to 2027
Figure 63: Asia Pacific Market Value Share (%), by Route of Administration, 2018 and 2027
Figure 64: Asia Pacific Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 65: Asia Pacific Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 66: Asia Pacific Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 67 : Asia Pacific Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
Figure 68: Asia Pacific Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027
Figure 69: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 to 2027
Figure 70: Latin America Market Value Share (%), by Type, 2018 and 2027
Figure 71: Latin America Market Attractiveness, by Type, 2019 to 2027
Figure 72: Latin America Market Value Share (%), by Drug Class, 2018 and 2027
Figure 73: Latin America Market Attractiveness, by Drug Class, 2019 to 2027
Figure 74: Latin America Market Value Share (%), by Route of Administration, 2018 and 2027
Figure 75: Latin America Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 76: Latin America Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 77: Latin America Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 78 : Latin America Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
Figure 79: Latin America Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027
Figure 80: Middle East & Africa Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027
Figure 81: Middle East & Africa Market Value Share (%), by Type, 2018 and 2027
Figure 82: Middle East & Africa Market Attractiveness, by Type, 2019 to 2027
Figure 83: Middle East & Africa Market Value Share (%), by Drug Class, 2018 and 2027
Figure 84: Middle East & Africa Market Attractiveness, by Drug Class, 2019 to 2027
Figure 85: Middle East & Africa Market Value Share (%), by Route of Administration, 2018 and 2027
Figure 86: Middle East & Africa Market Attractiveness, by Route of Administration, 2019 to 2027
Figure 87: Middle East & Africa Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 88: Middle East & Africa Market Attractiveness, by Distribution Channel, 2019 to 2027
Figure 89: Middle East & Africa Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
Arthritis Therapeutics Market